این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
صفحه اصلی
درباره پایگاه
فهرست سامانه ها
الزامات سامانه ها
فهرست سازمانی
تماس با ما
JCR 2016
جستجوی مقالات
پنجشنبه 24 مهر 1404
Tanaffos
، جلد ۲۲، شماره ۱، صفحات ۱۲۹-۱۳۵
عنوان فارسی
چکیده فارسی مقاله
کلیدواژههای فارسی مقاله
عنوان انگلیسی
Comparison of Longevity in Patients with Idiopathic Pulmonary Fibrosis Using Pirfenidone Versus Triple Therapy with Prednisolone, Azathioprine, and Acetylcysteine
چکیده انگلیسی مقاله
Background:
The effect of the combination of prednisolone, azathioprine, and acetylcysteine for the treatment of Idiopathic pulmonary fibrosis (IPF) is minimal. We aimed to investigate the effect of these drugs in case of intolerance to new anti-fibrotic drugs.
Materials and Methods:
This historical prospective study was performed on 91 patients with idiopathic pulmonary fibrosis who were referred to a pulmonologist in Mashhad during 2016-2020. Patients were divided into two groups, Pirfenidone which was prescribed for 46 subjects, and a combination of prednisolone, azathioprine, and acetylcysteine which was prescribed for 45 subjects. Patients were selected by convenience sampling and a life expectancy comparison between the two groups was performed by Cox regression.
Results:
There were no statistically significant differences between age, gender, and drug type in the two groups at the beginning of treatment. The death rate per year in the triple-drug treatment group was 44.44% (n = 20) and in the Pirfenidone treatment group was 11.08% (n=2). Of the 65 recovered population, 49% (22 patients) were in the triple-drug treatment group, and 78% (36 patients) were in the Pirfenidone treatment group which indicated that Pirfenidone has a significant impact on reducing death rate compared to triple-drug treatment (p-value=0.003 <0.05). Pirfenidone decreased the risk of death, compared to triple therapy (0.23 when death was set up as one in the triple-therapy group).
Conclusion:
Pirfenidone has a favorable effect on increasing life expectancy and triple therapy should be considered as short-term only in subjects intolerant to anti-fibrotic.
کلیدواژههای انگلیسی مقاله
acetylcysteine,Azathioprine,Idiopathic pulmonary fibrosis,Longevity,Prednisolone,Pirfenidone
نویسندگان مقاله
Mobin Soleimanian Asl |
Student Research Committee, Islamic Azad University, Mashhad Branch, Mashhad, Iran
Zahra Motakef |
Student Research Committee, Islamic Azad University, Mashhad Branch, Mashhad, Iran
Nazgol Behgam |
Student Research Committee, Islamic Azad University, Mashhad Branch, Mashhad, Iran
Soroush Attaran |
Mashhad University of Medical Sciences, Mashhad, Iran
Majid Mirsadraee |
Department of Internal Medicine, Islamic Azad University of Mashhad Branch, Mashhad, Iran
نشانی اینترنتی
https://www.tanaffosjournal.ir/article_708473_2f75fe6b8c46baa66938ce5d8b64a800.pdf
فایل مقاله
فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به:
صفحه اول پایگاه
|
نسخه مرتبط
|
نشریه مرتبط
|
فهرست نشریات